CHAPEL HILL, N.C., Jan. 11 /PRNewswire/ -- Today's top-level pharmaceutical companies devise a well-crafted launch strategy and seat the team that will carry out the plan as early as possible in product development, according to a study by pharmaceutical research firm, Best Practices, LLC.
As the marketplace becomes increasingly competitive, pharmaceutical companies are looking to invest people and money earlier in the product research and development phases than ever before.
"Best Practices in Global Pharmaceutical Launches," available at http://www3.best-in-class.com/rr897.htm reveals successful launch strategies, critical transition points and typical market need gaps. The key findings in the report are invaluable for companies to move forward toward the objective of developing their own world-class marketing and product launch capabilities.
The leading practices, managerial insights and benchmark metrics in
this report are drawn from in-depth surveys and lessons learned from
interviews with more than 25 executives directly involved in 12 successful
product launches. Additionally, pharmaceutical product launch information
was gathered from many valuable sources, including Best Practices, LLC's
own proprietary database.
An overview of some of the key findings:
-- Develop an integrated launch strategy to quickly achieve "share of
voice" in a competitive marketplace.
-- Create a cross-functional launch team to ensure a seamless product
-- Develop the initial life cycle management three to five years before
launch to identify options early for sustained product growth.
The "Best Practices in Global Pharmaceutical Launches" report is broken
into two parts. Part I analyzes investment patterns, timing and
organizational structure of global marketing launches. It also identifies
key launch activit
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved